UNICREDIT BANK/CALL/ROCHE GS/280/0.1/18.09.24 Share Price

Warrant

DE000HC9M4L1

Real-time BOERSE MUENCHEN 08:45:59 03/07/2024 BST
0.15 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/ROCHE GS/280/0.1/18.09.24
Current month-11.76%
1 month+66.67%
Date Price Change
03/07/24 0.15 0.00%
02/07/24 0.15 -6.25%
01/07/24 0.16 -5.88%
28/06/24 0.17 0.00%
27/06/24 0.17 0.00%

Real-time BOERSE MUENCHEN

Last update July 03, 2024 at 08:45 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC9M4L
ISINDE000HC9M4L1
Date issued 02/10/2023
Strike 280 CHF
Maturity 18/09/2024 (78 Days)
Parity 10 : 1
Emission price 0.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.91
Lowest since issue 0.001
Delta0.14x
Omega 20.45
Premium13.34x
Gearing150.27x
Moneyness 0.8875
Difference Strike 31.05 CHF
Difference Strike %+11.09%
Spread 0.06
Spread %30.00%
Theoretical value 0.1250
Implied Volatility 21.01 %
Total Loss Probability 90.70 %
Intrinsic value 0.000000
Present value 0.1250
Break even 281.22 €
Theta-0.02x
Vega0.02x
Rho0.01x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
248.5 CHF
Average target price
278.3 CHF
Spread / Average Target
+11.98%
Consensus